- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01663844
New Clinical Applications for Internet-based Cognitive Behavior Therapy for Insomnia and Depression
New Clinical Applications for Internet-based Cognitive Behavior Therapy: An Adaptive Treatment Strategy to Decrease the Number of Failed Treatments, and a Combination Treatment for Insomnia and Depression.
This study includes two sub-trials. Both are included in this singe registration since they have parallel inclusion of participants and have been approved by the Swedish ethics board together in one application.
Trial 1 includes patients with both insomnia and major or minor depression. Participants are randomized to either a combined therapist guided Internet-CBT for insomnia and depression, or to Internet-CBT for depression with an addition of a placebo intervention for insomnia. The primary purpose is to evaluate changes in insomnia and depression severity for the combination treatment compared to the depression treatment, after treatment and at 6 and 36 months follow up. A secondary purpose is to evaluate cognitive functioning before and after treatment, as well as cost effectiveness. Recruitment is done in the Stockholm County through mass media and the Internet psychiatry clinic's regular patient recruitment.
Trial 2 includes patients with insomnia who do not meet criteria for major or minor depression. All participants start therapist guided Internet-CBT for insomnia. After 4 weeks patients that are judged to be at risk of treatment failure are randomized to either continued treatment or treatment with added support intended to enhance outcome. The primary purpose is to evaluate change in insomnia severity for participants who get added support, compared to continued treatment with regular support level. A secondary purpose is to evaluate cognitive functioning before and after treatment, as well as cost effectiveness. Recruitment is done in the Stockholm County through mass media and the Internet psychiatry clinic's regular patient recruitment.
NOTE:
The first participants in trial 1 will be regarded as pilots, due to problems with the experimental treatment: technical issues as well as problems with the design of treatment modules. These problems were corrected when discovered. 12 participants in the experimental arm were affected by these errors. The pilot participants will not be included in the main analyses of data. This was decided upon on 31st of October 2014.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Stockholm, Sweden, S-14186
- Internetpsykiatrienheten (Internet Psychiatry Clinic) Psykiatri Sydväst, SLSO
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clinical level of Insomnia (more than 10 on ISI)
- Meets criteria for Insomnia according to DSM-IV-TR
- Enough language skills
- Only Trial 1: Meets criteria for Major or Minor Depressive Disorder according to DSM-IV-TR (for minor depression a MADRS-S-level of >19 is required).
Exclusion Criteria:
- Sleep disorders requiring other treatment
- Alcohol/drugs abuse
- Started to use or changed the dose of antidepressant drug during the last 2 months
- Somatic or psychiatric conditions requiring acute care
- Working night shifts
- Only Trial 2: Meets criteria for Major or Minor Depressive Disorder according to DSM-IV-TR (for minor depression a MADRS-S-level of >19 is required for exclusion).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: (Study 1) ICBT for insomnia and depression
|
(Study 1) A 12 week long, structured self-help program with weekly reports to, and feedback from, a CBT therapist over the Internet.
Includes traditional CBT-methods for insomnia and depression.
|
Active Comparator: (Study 1) ICBT for depr. plus placebo insomnia intervention
|
(Study 1) A 12 week long, structured self-help program with weekly reports to, and feedback from, a CBT therapist over the Internet.
Includes traditional CBT-methods for depression.
A placebo intervention for insomnia is added.
|
Experimental: (Study 2) ICBT for insomnia with added support
|
(Study 2) A 9 week long, structured self-help program with weekly reports to, and feedback from, a CBT therapist over the Internet.
Includes traditional CBT-methods for insomnia plus extra therapist support.
|
Active Comparator: (Study 2) ICBT for insomnia with regular level of support
|
(Study 2) A 9 week long, structured self-help program with weekly reports to, and feedback from, a CBT therapist over the Internet.
Includes traditional CBT-methods for insomnia.
Regular therapist support.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change (from baseline) in Insomnia Severity Index (ISI)
Time Frame: 0, 6 and 36 months after treatment
|
7-item, self-rated questionnaire measuring change in insomnia severity.
Bastien, C. H., Vallières, A., & Morin, C. M. (2001).
Validation of the Insomnia Severity Index as an outcome measure for insomnia research.
Sleep Medicine, 2, 297-307.
|
0, 6 and 36 months after treatment
|
Change (from baseline) in Montgomery Asberg Depression Rating Scale, MADRS-S
Time Frame: 0, 6 and 36 months after treatment
|
Defined as secondary outcome measure in Trial 2. The use of two primary outcomes in trial 1 is motivated since participants have both diagnoses and the purpose is to look at effects on both insomnia and depression. The MADRS-S is a 9-item self-rated measure of change in depression severity. It also screens for suicidality. Mattila-Evenden, M., Svanborg, P., Gustavsson, P., & Åsberg, M. (1996). Determinants of self-rating and expert rating concordance in psychiatric out-patients, using the affective subscales of CPRS. Acta Psychiatr Scand, 94, 386-396. |
0, 6 and 36 months after treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change (from baseline) in Sleep Diary
Time Frame: Directly after treatment
|
One week of self-ratings on a number of sleep parameters, resulting in measures of sleep latency, total sleep time, sleep efficacy, number of nighttime awakenings, subjective sleep quality and daytime functioning.
|
Directly after treatment
|
Changes (from baseline) in Actigraph data
Time Frame: Directly post treatment
|
An actigraph is placed on the participant's arm for one week.
They measure participants' activity in the form of movements.
It will be used for acquiring sleep data and calculate sleep latency, total sleep time, sleep efficacy, number of nighttime awakenings and daytime activity.
|
Directly post treatment
|
Change (from baseline) in Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry (TIC-P)
Time Frame: 0, 6 and 36 months after treatment
|
Health economic questionnaire evaluation cost for health care, absence of work capacity and related costs. Hakkaart-Van Roijen, L.,Van Straten, A., & Donker, M. (2002). Manual: Trimbos/iMTA Questionnaire for Costs Associated with Psychiatric Illness. Rotterdam: Erasmus University |
0, 6 and 36 months after treatment
|
Change (from baseline) in Cognitive functioning
Time Frame: Directly at post-treatment
|
Computer based testing of executive functions, concentration, speed and memory.
|
Directly at post-treatment
|
Change (from baseline) in EuroQuol. EQ-5D
Time Frame: 0, 6 and 36 months after treatment
|
General quality of life measure to complement the TIC-P in health economic analysis. Hinz, A., Klaiberg, A., Brahler, E., & Konig, H.H. (2006). The Quality of Life Questionnaire EQ-5D: modelling and norm values for the general population. Psychother.Psychosom.Med.Psychol., 56, 42-48. |
0, 6 and 36 months after treatment
|
Change (from baseline) in Sheehan Disability Scale
Time Frame: 0, 6 and 36 months after treatment
|
Measures daily life functioning.
Sheehan, D. V. (1983).
The Anxiety disease.
Scribner: New York
|
0, 6 and 36 months after treatment
|
Change (from baseline) in Clinical Outcome in Routine Evaluation - 10, CORE-OM
Time Frame: 0, 6 and 36 months after treatment
|
Measures psychological health in general.
Evans, C., Connell, J., Barkham, M., Margison, F., McGrath, G., Mellor-Clark, J. & Audin, K. (2002).
Towards a standardised brief outcome measure: psychometric properties and utility of the CORE-OM.
The British journal of psychiatry : the journal of mental science 180, 51-60.
|
0, 6 and 36 months after treatment
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Viktor Kaldo, PhD, Karolinska Institutet
Publications and helpful links
General Publications
- Kraepelien M, Blom K, Forsell E, Hentati Isacsson N, Bjurner P, Morin CM, Jernelov S, Kaldo V. A very brief self-report scale for measuring insomnia severity using two items from the Insomnia Severity Index - development and validation in a clinical population. Sleep Med. 2021 May;81:365-374. doi: 10.1016/j.sleep.2021.03.003. Epub 2021 Mar 16.
- Forsell E, Jernelov S, Blom K, Kraepelien M, Svanborg C, Andersson G, Lindefors N, Kaldo V. Proof of Concept for an Adaptive Treatment Strategy to Prevent Failures in Internet-Delivered CBT: A Single-Blind Randomized Clinical Trial With Insomnia Patients. Am J Psychiatry. 2019 Apr 1;176(4):315-323. doi: 10.1176/appi.ajp.2018.18060699. Epub 2019 Jan 30.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012/934-31/4
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia
-
Leiden UniversityBioClock Consortium; Caring UniveristiesCompleted
-
National Science Council, TaiwanCompleted
-
Sunshine Lake Pharma Co., Ltd.Unknown
-
Pfizer's Upjohn has merged with Mylan to form Viatris...Completed
-
Massachusetts General HospitalNational Institutes of Health (NIH)Completed
-
IpsenCompletedThe Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over (QUALISLEEP)InsomniaRussian Federation
-
Charite University, Berlin, GermanyCompleted
-
Roxane LaboratoriesCompleted
-
Butler HospitalSunovionCompleted
Clinical Trials on Therapist guided Internet-CBT for insomnia and depression
-
Karolinska InstitutetRegion StockholmCompleted
-
Ersta Sköndal University CollegeKarolinska Institutet; Region StockholmCompletedInsomnia | Bereavement
-
Ontario Shores Centre for Mental Health SciencesMindbeaconWithdrawnMajor Depressive Disorder
-
Karolinska InstitutetRegion StockholmRecruiting
-
Kaiser PermanenteOregon Health and Science UniversityCompleted
-
Karolinska InstitutetRegion StockholmCompletedMajor Depressive DisorderSweden
-
Linkoeping UniversityCompleted
-
Linkoeping UniversityCompletedDepression | Anxiety DisordersSweden
-
The University of Hong KongChinese University of Hong Kong; University of OxfordCompletedDepression | InsomniaHong Kong
-
Jonkoping UniversityCompletedCardiovascular Diseases | InsomniaSweden